Skip to main content
OpenTrials

Clinical trial condition

PI3K Pathway Inhibition

Explore clinical trials studying PI3K Pathway Inhibition. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

PI3K Pathway Inhibition trial results

Completed

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

NCT02058381

Conditions
PI3K Pathway Inhibition, Pre-menopausal Breast Cancer
Locations
  • Novartis Investigative Site Hong Kong
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Gyeonggi-do, Korea, South Korea
  • Novartis Investigative Site Seoul, Korea, South Korea
View all 15 locations
View Trial Details

Related conditions